跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPIKEVAX XBB.1.5 50 MICROGRAMOS DE DISPERSION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SPIKEVAX XBB.1.5 50 MICROGRAMOS DE DISPERSION INYECTABLE
Approved
STANDARD
SPIKEVAX XBB.1.5 50 MICROGRAMOS DE DISPERSION INYECTABLE
Moderna Biotech Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 26, 2023
Approval ID
d8505e2506af5394
Company
Moderna Biotech Spain S.L.
Type
Standard
Approval Details
Approval Id
d8505e2506af5394
Drug Cima Aemps Name
SPIKEVAX XBB.1.5 50 MICROGRAMOS DE DISPERSION INYECTABLE
Register Number
1201507014
Holder Company Name
Moderna Biotech Spain S.L.
Marketing Company Name
Moderna Biotech Spain S.L.
Authorization Date
2023-09-26
Dosage Form
DISPERSIÓN INYECTABLE
Dose
50 MICROGRAMOS
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Moderna Biotech Spain S.L.
Active Ingredients
ANDUSOMERAN
50 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 26, 2023
Approval ID
d8505e2506af5394
Type
Standard
Back to CIMA-AEMPS Approvals